Jérôme Giustiniani

2.1k total citations
45 papers, 1.4k citations indexed

About

Jérôme Giustiniani is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jérôme Giustiniani has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 13 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jérôme Giustiniani's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (9 papers) and Reproductive System and Pregnancy (7 papers). Jérôme Giustiniani is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (9 papers) and Reproductive System and Pregnancy (7 papers). Jérôme Giustiniani collaborates with scholars based in France, United Kingdom and United States. Jérôme Giustiniani's co-authors include Armand Bensussan, Christian Garbar, Anne Marie‐Cardine, Yacine Merrouche, Frank Antonicelli, Jérémy Bastid, Gilles Alberici, Emilie Laprévotte, Jean‐François Eliaou and Stéphanie Cochaud and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jérôme Giustiniani

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Giustiniani France 21 922 456 259 177 149 45 1.4k
Julio Gómez‐Rodríguez United States 19 1.3k 1.4× 289 0.6× 300 1.2× 193 1.1× 269 1.8× 29 1.8k
Weili Zhao China 21 254 0.3× 336 0.7× 485 1.9× 379 2.1× 111 0.7× 73 1.2k
Lev Shvidel Israel 23 819 0.9× 376 0.8× 253 1.0× 475 2.7× 573 3.8× 82 1.7k
J A Hansen United States 23 1.4k 1.5× 385 0.8× 404 1.6× 140 0.8× 165 1.1× 35 2.3k
Christoph Bergmann Germany 22 1.6k 1.7× 953 2.1× 411 1.6× 56 0.3× 47 0.3× 54 2.3k
AH Dalloul France 14 533 0.6× 145 0.3× 238 0.9× 119 0.7× 126 0.8× 24 917
Paolo Carrega Italy 23 2.0k 2.2× 922 2.0× 300 1.2× 82 0.5× 52 0.3× 40 2.5k
Jason Foley United States 17 922 1.0× 482 1.1× 280 1.1× 32 0.2× 116 0.8× 24 1.4k
Andrea G.S. Buggins United Kingdom 19 628 0.7× 251 0.6× 332 1.3× 253 1.4× 474 3.2× 33 1.1k
Laura C. Hooper United States 18 350 0.4× 197 0.4× 371 1.4× 214 1.2× 394 2.6× 24 1.1k

Countries citing papers authored by Jérôme Giustiniani

Since Specialization
Citations

This map shows the geographic impact of Jérôme Giustiniani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Giustiniani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Giustiniani more than expected).

Fields of papers citing papers by Jérôme Giustiniani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Giustiniani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Giustiniani. The network helps show where Jérôme Giustiniani may publish in the future.

Co-authorship network of co-authors of Jérôme Giustiniani

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Giustiniani. A scholar is included among the top collaborators of Jérôme Giustiniani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Giustiniani. Jérôme Giustiniani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devy, Jérôme, Jérôme Giustiniani, Yacine Merrouche, et al.. (2024). Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications. Breast Cancer Research. 26(1). 28–28. 1 indexed citations
2.
Muharam, Raden, et al.. (2022). Cytotoxic activity of peripheral blood mononuclear cells in patients with endometriosis: A cross-sectional study. International Journal of Reproductive BioMedicine (IJRM). 20(8). 691–700. 3 indexed citations
3.
Giustiniani, Jérôme, et al.. (2018). The Interleukin-17 Family of Cytokines in Breast Cancer. International Journal of Molecular Sciences. 19(12). 3880–3880. 52 indexed citations
4.
Hocine, Hocine R., Hicham El Costa, Noémie Dam, et al.. (2017). Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Scientific Reports. 7(1). 41125–41125. 13 indexed citations
5.
Garbar, Christian, C. Mascaux, Jérôme Giustiniani, Yacine Merrouche, & Armand Bensussan. (2017). Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231. Scientific Reports. 7(1). 7201–7201. 48 indexed citations
6.
Bensussan, Armand, et al.. (2016). A FOCUS ON IL-17 TARGETING TREATMENTS IN PSORIASIS. 1(2). 22–26. 2 indexed citations
7.
Giustiniani, Jérôme, Christian Garbar, Frank Antonicelli, et al.. (2016). Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type. International Journal of Molecular Sciences. 17(9). 1433–1433. 113 indexed citations
8.
Masson, Annie, Jérôme Giustiniani, Anne Marie‐Cardine, et al.. (2016). Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes. OncoImmunology. 5(5). e1127493–e1127493. 13 indexed citations
9.
Plée, J., Sébastien Le Jan, Jérôme Giustiniani, et al.. (2015). Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome. Scientific Reports. 5(1). 18001–18001. 59 indexed citations
10.
Cochaud, Stéphanie, Yacine Merrouche, Christian Garbar, et al.. (2015). IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells. Scientific Reports. 5(1). 11874–11874. 48 indexed citations
11.
Bastid, Jérémy, Nathalie Bonnefoy, Cécile Déjou, et al.. (2014). Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity. Cancer Immunology Research. 3(3). 254–265. 172 indexed citations
12.
Cochaud, Stéphanie, Jérôme Giustiniani, Clémence Thomas, et al.. (2013). IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Scientific Reports. 3(1). 3456–3456. 113 indexed citations
13.
Bouteiller, Philippe Le, Julie Tabiasco, Beáta Polgár, et al.. (2011). CD160: A unique activating NK cell receptor. Immunology Letters. 138(2). 93–96. 64 indexed citations
14.
Ortonne, Nicolás, C. Ram‐Wolff, Jérôme Giustiniani, et al.. (2010). Human and Mouse Mast Cells Express and Secrete the GPI-Anchored Isoform of CD160. Journal of Investigative Dermatology. 131(4). 916–924. 14 indexed citations
15.
Giustiniani, Jérôme, Anne Marie‐Cardine, & Armand Bensussan. (2007). A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity. The Journal of Immunology. 178(3). 1293–1300. 49 indexed citations
16.
Giustiniani, Jérôme, Nicolás Meyer, Valérie Schiavon, et al.. (2007). Identification of a Novel CD160+CD4+ T-Lymphocyte Subset in the Skin: A Possible Role for CD160 in Skin Inflammation. Journal of Investigative Dermatology. 127(5). 1161–1166. 27 indexed citations
17.
Rey, Jérôme, Jérôme Giustiniani, Françoise Mallet, et al.. (2006). The co‐expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160‐mediated cytolytic effector function. European Journal of Immunology. 36(9). 2359–2366. 40 indexed citations
18.
Bouaziz, Jean‐David, Nicolás Ortonne, Jérôme Giustiniani, et al.. (2005). Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients. Journal of Investigative Dermatology. 125(6). 1273–1278. 32 indexed citations
19.
Giustiniani, Jérôme, Anne Marie‐Cardine, Georges Beaud, et al.. (2005). Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. Oncogene. 25(19). 2807–2811. 23 indexed citations
20.
Bouteiller, Philippe Le, Alíz Barakonyi, Jérôme Giustiniani, et al.. (2002). Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proceedings of the National Academy of Sciences. 99(26). 16963–16968. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julio Gómez‐Rodríguez Breakdown of academic impact, for papers by Weili Zhao Breakdown of academic impact, for papers by Lev Shvidel Breakdown of academic impact, for papers by J A Hansen Breakdown of academic impact, for papers by Christoph Bergmann Breakdown of academic impact, for papers by AH Dalloul Breakdown of academic impact, for papers by Paolo Carrega Breakdown of academic impact, for papers by Jason Foley Breakdown of academic impact, for papers by Andrea G.S. Buggins Breakdown of academic impact, for papers by Laura C. Hooper
Rankless by CCL
2026